Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
Breast Cancer Research : BCR
|
May 16, 2020
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial
Cornelia Kolberg-Liedtke, Oleg Gluz, Fred Heinisch, et al.
The Journal of Pathology
|
March 3, 2025
Afadin loss induces breast cancer metastasis through destabilisation of E-cadherin to F-actin linkage
Max Ak Rätze, Lotte Nfl Enserink, Noboru Ishiyama, et al.
Cancers
|
November 27, 2025
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>)
Alexander Scheiter, Sven Mattern, Verena Gassenmaier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 5, 2025
Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast
Giuseppe Floris, Lounes Djerroudi, Gitte Zels, et al.
Plos One
|
June 5, 2012
Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer
Jeroen F Vermeulen, Robert A H van de Ven, Cigdem Ercan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 6, 2025
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial
Martin Radner, Sandy Burmeister, Katarzyna Jóźwiak, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 17, 2017
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β
Mieke Raap, Malte Gronewold, Henriette Christgen, et al.
Breast (Edinburgh, Scotland)
|
June 24, 2021
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials
Monika Graeser, Nadia Harbeck, Oleg Gluz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2026
Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
Oleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
NPJ Breast Cancer
|
November 8, 2022
Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer
Caner Mercan, Maschenka Balkenhol, Roberto Salgado, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
Breast Cancer Research : BCR
|
May 16, 2020
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial
Cornelia Kolberg-Liedtke, Oleg Gluz, Fred Heinisch, et al.
The Journal of Pathology
|
March 3, 2025
Afadin loss induces breast cancer metastasis through destabilisation of E-cadherin to F-actin linkage
Max Ak Rätze, Lotte Nfl Enserink, Noboru Ishiyama, et al.
Cancers
|
November 27, 2025
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>)
Alexander Scheiter, Sven Mattern, Verena Gassenmaier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 5, 2025
Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast
Giuseppe Floris, Lounes Djerroudi, Gitte Zels, et al.
Plos One
|
June 5, 2012
Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer
Jeroen F Vermeulen, Robert A H van de Ven, Cigdem Ercan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 6, 2025
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial
Martin Radner, Sandy Burmeister, Katarzyna Jóźwiak, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 17, 2017
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β
Mieke Raap, Malte Gronewold, Henriette Christgen, et al.
Breast (Edinburgh, Scotland)
|
June 24, 2021
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials
Monika Graeser, Nadia Harbeck, Oleg Gluz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2026
Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
Oleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
NPJ Breast Cancer
|
November 8, 2022
Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer
Caner Mercan, Maschenka Balkenhol, Roberto Salgado, et al.
Page
of 11